Haemonetics (HAE) Tops Q4 EPS by 1c, Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $81.24 -2.66%
Revenue Growth %: +8.4%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +8.4%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.43, $0.01 better than the analyst estimate of $0.42. Revenue for the quarter came in at $233.6 million versus the consensus estimate of $227.12 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Oilfield firm SLB's profit rises on international drilling demand
- Lakeland Bancorp (LBAI) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
